These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1974926)

  • 1. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.
    Chalmers IM; Sitar DS; Hunter T
    J Rheumatol; 1990 Jun; 17(6):764-70. PubMed ID: 1974926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z; Vácha J; Trnavský K
    Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sulfasalazine in the treatment of rheumatoid arthritis. A multicenter open study of 150 patients during 6 months].
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):707-13. PubMed ID: 1363986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a clinical trial of sulfasalazine in rheumatoid arthritis].
    Pelísková Z; Trnavský K; Gatterová J; Macek J
    Vnitr Lek; 1989 Jan; 35(1):62-7. PubMed ID: 2564708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the AIMS questionnaire in the evaluation of sulphasalazine treatment in rheumatoid arthritis.
    Pelísková Z; Trnavský K; Vácha J
    Z Rheumatol; 1987; 46(3):124-8. PubMed ID: 2442919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5-year followup.
    Jones E; Jones JV; Woodbury JF
    J Rheumatol; 1991 Feb; 18(2):195-8. PubMed ID: 1673722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of responses to and adverse effects of graded doses of sulfasalazine in the treatment of rheumatoid arthritis.
    Skosey JL
    J Rheumatol Suppl; 1988 Sep; 16():5-8. PubMed ID: 2903927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine therapy for juvenile rheumatoid arthritis.
    Imundo LF; Jacobs JC
    J Rheumatol; 1996 Feb; 23(2):360-6. PubMed ID: 8882047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biochemical assessment of sulphasalazine in rheumatoid arthritis.
    Bird HA; Dixon JS; Pickup ME; Rhind VM; Lowe JR; Lee MR; Wright V
    J Rheumatol; 1982; 9(1):36-45. PubMed ID: 6123598
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response.
    Newman ED; Perruquet JL; Harrington TM
    J Rheumatol; 1991 Sep; 18(9):1379-82. PubMed ID: 1684619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sulfasalazine (Azulfidine RA) versus aurothioglucose in therapy of chronic polyarthritis--status report of an open, comparative, multicenter long-term study].
    Schattenkirchner M
    Z Rheumatol; 1987; 46(2):67-70. PubMed ID: 2885986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sulfasalazine or salazosulfapyridine in the treatment of rheumatoid polyarthritis. An open study of 46 patients. Review of the literature].
    Trèves R; Morvan C; Bitaudeau P; Clément S; Liozon E; Arnaud M; Archambeaud-Mouveroux F; Desproges-Gotteron R
    Rev Rhum Mal Osteoartic; 1988; 55(9):641-6. PubMed ID: 2903546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatoid pericarditis: correlation with immunologic parameters].
    Alusík S; Skalická H; Vencovský J; Kohoutová M
    Vnitr Lek; 1995 Nov; 41(11):764-6. PubMed ID: 8553595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy study of chronic polyarthritis with sulfasalazine with special emphasis on the profile of side effects].
    Lonauer G
    Z Rheumatol; 1990; 49(1):44-9. PubMed ID: 1970208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.